Nootropics Index - Save on smarter supplements
Nootropics>Vitamins & vitamin-like compounds>Vitamin D
Vitamins & vitamin-like compounds

Vitamin D

vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol)

Vitamin D is a fat-soluble nutrient available as D3 and D2. For generally healthy adults using an ordinary labelled product, base risk is minimal; compare form, total intake from foods and supplements, and higher-dose context. It is not a reliable acute focus or memory supplement for people with adequate status.

Healthy AgingCellular SupportHormonal Axis RelatedFood DerivedFat SolubleBioavailability SensitiveClinical Research
Updated July 2026/5 min read/8 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

Vitamin D forms and comparison

1

Vitamin D supplements usually provide D3 (cholecalciferol) or D2 (ergocalciferol). Compare labels in both micrograms and IU because either unit may be prominent.

Comparison focus1
Compare D3 versus D2, total vitamin D from food and supplements, label dose, and whether a product adds calcium or vitamin K. Do not read vitamin D essentiality as proof of direct focus or memory enhancement.

Evidence limits for nootropic use

7

Vitamin D has established nutrient roles and intake guidance. Adult cognitive trial syntheses are mixed and do not establish reliable direct focus or memory benefit for people with adequate status.

02

Names, aliases and forms

Common Namesvitamin D3; vitamin D2
Chemical Namescholecalciferol; ergocalciferol
Cas Numbers67-97-0; 50-14-6
03

Mechanisms of action

Status is not cognitive enhancement

1

Vitamin D promotes intestinal calcium absorption and helps maintain calcium and phosphate concentrations for normal bone mineralization. Those established physiological roles do not demonstrate an acute nootropic effect.

04

Potential effects and evidence map

Vitamin D has established essential-nutrient and intake-guidance evidence, but adult cognitive trial syntheses remain mixed and do not establish reliable direct focus or memory benefit for people with adequate status. D2 and D3 both raise 25(OH)D; D3 generally raises it more and maintains it longer.

Effect domainMagnitudeGrade
Cellular / long-term brain support7
UnknownConfidence: Medium

Vitamin D essentiality does not establish a direct long-term brain-support effect for adults with adequate status.

Note Do not turn mineral physiology into a brain-benefit rating.

0/5
C
Mood / wellbeing1
UnknownConfidence: Medium

Evidence does not establish vitamin D as a reliable mood supplement for adults with adequate status.

Note Do not infer a broad mood benefit from nutrient essentiality.

0/5
C
Focus / attention7
UnknownConfidence: Medium

Cognitive trial syntheses do not establish vitamin D as a reliable acute focus supplement for adults with adequate status.

Note Cognition findings are mixed and vary by population and baseline status.

0/5
C
Memory / learning8
UnknownConfidence: Medium

Cognitive trial syntheses do not establish vitamin D as a general memory-enhancement supplement for adults with adequate status.

Note Cognition findings are mixed and may differ in deficient or vulnerable populations.

0/5
C
05

Typical dosages and timing

Typical
15-20 mcg/day
Not a recommendation
Lower bound
15 mcg/day
Profile value
Upper bound
20 mcg/day
Profile value
Age-based reference intake115-20 mcg/day

For U.S. adults, the RDA is 15 mcg/day (600 IU) through age 70 and 20 mcg/day (800 IU) after age 70. This is reference-intake context, not a personalized dosing instruction.

All sources1100 mcg/day

The U.S. adult upper intake level is 100 mcg/day (4,000 IU) from all foods, beverages, and supplements combined. It is a safety limit, not an intake target.

06

Timing & effect horizon

Effect horizonCumulative
Cumulative
25(OH)D half-life1Cumulative
15 days
Status changes gradually1

25(OH)D, the usual marker of vitamin D status, has a circulating The time for blood levels to fall by half during the final elimination phase.Source of about 15 days. This is a cumulative status process, not a same-day nootropic effect.

07

Safety, side effects and risk profile

High-dose caution1
Base risk is minimal for generally healthy adults using ordinary labelled products. Excess supplemental intake can raise calcium and can cause kidney complications, especially when total intake and calcium-containing products are not accounted for.
Liver / kidney caution1
Confidence: High

Excess supplemental vitamin D can raise calcium and cause kidney complications; this is not the expected outcome at ordinary labelled product use.

Note Keep the severe toxicity context tied to excess intake and susceptible people.

1/5
B
GI discomfort1
Confidence: High

Nausea, constipation, and poor appetite are associated with hypercalcemia from excessive vitamin D intake, rather than typical product use.

Note These are excess-intake signals, not expected typical-dose effects.

1/5
B
Evidence uncertainty1
Confidence: High

Direct nootropic benefit is uncertain; higher intake does not make cognitive benefit more likely.

Note Keep evidence limits distinct from intrinsic toxicity.

1/5
B
Interaction risk1
Confidence: High

Medication interactions matter mainly in specific contexts, including thiazide diuretics and medicines that affect absorption or vitamin D metabolism.

Note Contextual interaction caution; it does not raise the healthy-adult base risk.

1/5
B
calcium-related1nausea, constipation, weakness

Nausea, vomiting, constipation, poor appetite, weakness, thirst, frequent urination, and kidney stones can occur with hypercalcemia caused by excessive vitamin D intake.

08

Interactions and cautions

context-dependent1

NIH lists interactions or status effects involving orlistat, statins, corticosteroids, and thiazide diuretics. Thiazide diuretics combined with vitamin D can increase hypercalcemia risk in susceptible people.

09

Legal and regulatory status

U.S.; as of 20246

In the United States, vitamin D products marketed as dietary supplements are regulated differently from conventional foods and drugs. As of 2024, manufacturers and distributors are responsible for product safety and labeling before marketing, and FDA can act against adulterated or misbranded products.

10

How it compares

cholecalciferol1

Both D3 and D2 raise 25(OH)D. NIH summarizes that D3 generally raises 25(OH)D more and maintains higher levels for longer.

ergocalciferol1

D2 is another established vitamin D form. Compare the declared form, dose, dietary sourcing, and total intake rather than assuming that forms are interchangeable by default.

11

Practical buying and quality notes

  • Compare D3 or D2, micrograms and IU, serving size, total vitamin D across a stack, added calcium or vitamin K, and third-party testing. Compare price only across like-for-like dose and form.1
12

FAQ

Is vitamin D a nootropic?

1

Not as an acute cognitive enhancer. Vitamin D has established nutrient roles, but that does not establish a reliable focus or memory benefit for adults with adequate status.

How should vitamin D labels be compared?

1

Compare micrograms and IU, total intake from foods and supplements, and the declared D3 or D2 form. One microgram of vitamin D equals 40 IU; the U.S. adult upper intake level is 100 mcg (4,000 IU) from all sources.

Is D3 better than D2?

1

Both D3 and D2 can raise 25(OH)D. NIH summarizes that D3 generally raises it more and maintains higher levels longer, so form belongs in any like-for-like comparison.

When does extra caution matter?

1

Extra caution matters with high-dose products, multiple vitamin D sources, calcium-containing stacks, kidney vulnerability, and medicines that affect calcium or vitamin D handling.

13

References

  1. National Institutes of Health Office of Dietary Supplements. Vitamin D Fact Sheet for Health Professionals.
  2. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press; 2011.
  3. EFSA NDA Panel. Dietary reference values for vitamin D. EFSA Journal. 2016;14(10):4547.
  4. PubChem Compound Summary for Cholecalciferol. National Center for Biotechnology Information.
  5. PubChem Compound Summary for Ergocalciferol. National Center for Biotechnology Information.
  6. U.S. Food and Drug Administration. Dietary Supplements.
  7. Beauchet O, Cooper-Brown L, Allali G. Vitamin D Supplementation and Cognition in Adults: A Systematic Review of Randomized Controlled Trials. CNS Drugs. 2021;35(12):1249-1264.
  8. Chen W-Y, Cheng Y-C, Chiu C-C, et al. Effects of Vitamin D Supplementation on Cognitive Outcomes: A Systematic Review and Meta-Analysis. Neuropsychology Review. 2024;34(2):568-580.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.